The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period 11-17 April 2021 and includes updates on COVID-19, influenza, and Ebola virus disease.
ECDC, together with the European Commission’s Directorate-General for Health and Food Safety, and supported by the Commission’s Directorate-General for Neighbourhood and Enlargement Negotiations, organised a stress test of the logistical aspects of COVID-19 vaccination deployment plans for the Western Balkans.
ECDC, together with the European Commission’s Directorate-General for Health and Food Safety, organised a stress test of the logistical aspects of COVID-19 vaccination deployment plans. Twelve EU/EEA Member States participated in this stress test, a focused simulation exercise conducted in two rounds, one in mid-December 2020 and the second in early January 2021.
The purpose of this document is to provide an initial illustration of how the COVID-19 response could unfold in the vaccination era, given the emergence and replacement of the predominant strain with a novel, more transmissible variant.
This document builds on a previously published ECDC report, ‘Key aspects regarding the introduction and prioritisation of COVID-19 vaccination in the EU/EEA and the UK’ [15]. By using mathematical modelling, this document provides EU/EEA countries with information on factors that may affect the choice of COVID-19 vaccination
This document provides an overview of the key aspects related to the initial phases following the introduction of one or more COVID-19 vaccines in the European Union and European Economic Area (EU/EEA) and the United Kingdom (UK). The aim is to support but not define EU policy on COVID-19 vaccination.
This report provides an analysis of the external quality assessment (EQA) for the antimicrobial susceptibility testing (AST) performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2019. A total of 952 laboratories (1–95 per country) from 30 EU/EEA countries participated in the EQA exercise.